Document resource
The NHS spent £574m on tirzepatide (Mounjaro) last year, an almost fivefold annual increase and around 5% of its total prescribing bill of £11.6bn, new data show.
Annotated abstract
Can the NHS afford Mounjaro? It spent £574m on the jab last year despite most eligible patients not getting it
bmj · 2026-06-28 · canonical JSON source